Alnylam Pharmaceuticals
Fen Chen is a highly skilled scientist with extensive experience in the biopharmaceutical industry and research institutions. Currently serving as Principal Associate Scientist at Alnylam Pharmaceuticals, Fen Chen has previously held positions as Principal Research Associate at Voyager Therapeutics, Inc. and Principal Research Associate at Sanofi Genzyme. Fen Chen’s foundational research expertise was developed during a tenure as a Research Fellow at Boston Children's Hospital and further enhanced through a postdoctoral associate role at the Massachusetts Institute of Technology (MIT).
This person is not in any teams
Alnylam Pharmaceuticals
32 followers
Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.